🇺🇸 Varicella Vaccine in United States
89 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 89
Most-reported reactions
- Headache — 16 reports (17.98%)
- Urticaria — 13 reports (14.61%)
- Pruritus — 11 reports (12.36%)
- Pharyngeal Oedema — 10 reports (11.24%)
- Throat Tightness — 10 reports (11.24%)
- Fatigue — 7 reports (7.87%)
- Herpes Zoster — 6 reports (6.74%)
- Rash — 6 reports (6.74%)
- Blood Creatinine Increased — 5 reports (5.62%)
- Blood Pressure Increased — 5 reports (5.62%)
Other Immunology / Infectious Disease approved in United States
Frequently asked questions
Is Varicella Vaccine approved in United States?
Varicella Vaccine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Varicella Vaccine in United States?
Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.